G to A transition at the first nucleotide of intron 1, which alters the splice donor site. This is predicted to generate a peptide truncated after exon 1 with 22 extraneous amino acids at the C-terminus encoded by intronic sequences.
G9869531A
G?A
G to A transition at the first nucleotide of intron 1, which alters the splice donor site. This is predicted to generate a peptide truncated after exon 1 with 22 extraneous amino acids at the C-terminus encoded by intronic sequences. The first coding exon was counted as exon 1.
Mutant flies show increased resistance to the nAChRα6 agonist spinosad compared to wild-type controls.
Mutant adults are specifically resistant to spinosyns and synthetically-modified spinosyns (spinosyn A, spinosad and spinetoram) compared to controls, but are not resistant to other insecticides (imidacloprid, acetamiprid, thiamethoxam, methyllycaconitine, emamectin, avermectin B[[1a]], permethrin and indoxacarb).
Homozygous larvae display no overt differences in firing patterns of isolated ventral ganglia compared to wild type, with substantial levels of spontaneous firing of action potentials being observed in both cases. In the presence of 100 nM spinosyn A, wild-type ganglia respond with an increase in neuronal firing (9 out of 9 tested ganglia), while homozygous ganglia produce no response to this concentration of spinosyn A. Both wild-type and homozygous ganglia are capable of responding to higher concentrations of spinosyn A (10μM).
nAcRα-30DDAS1 mutants exhibit resistance to the insecticide spinosad.
nAChRα6DAS1 has decreased size | larval stage phenotype, non-enhanceable by nAChRα1MI00453/nAChRα1MI11851
nAChRα6DAS1 has decreased size | larval stage phenotype, non-enhanceable by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 has decreased size | larval stage phenotype, non-suppressible by nAChRα1MI00453/nAChRα1MI11851
nAChRα6DAS1 has decreased size | larval stage phenotype, non-suppressible by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 is an enhancer of decreased body size | pupal stage phenotype of Nf1E2
nAChRα6DAS1 has LNv neuron | larval stage phenotype, non-enhanceable by nAChRα1MI00453/nAChRα1MI11851
nAChRα6DAS1 has dendrite | larval stage phenotype, non-enhanceable by nAChRα1MI00453/nAChRα1MI11851
nAChRα6DAS1 has dendrite | larval stage phenotype, non-enhanceable by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 has LNv neuron | larval stage phenotype, non-enhanceable by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 has synapse | larval stage | decreased number phenotype, non-enhanceable by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 has presynapse | larval stage phenotype, non-enhanceable by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 has LNv neuron | larval stage phenotype, non-suppressible by nAChRα1MI00453/nAChRα1MI11851
nAChRα6DAS1 has dendrite | larval stage phenotype, non-suppressible by nAChRα1MI00453/nAChRα1MI11851
nAChRα6DAS1 has dendrite | larval stage phenotype, non-suppressible by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 has LNv neuron | larval stage phenotype, non-suppressible by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 has synapse | larval stage | decreased number phenotype, non-suppressible by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 has presynapse | larval stage phenotype, non-suppressible by nAChRα1UAS.cRa/Scer\GAL4P2.4.Pdf
nAChRα6DAS1 is partially rescued by nAChRα6UAS.RE/Scer\GAL4P2.4.Pdf